FUM — Futura Medical Income Statement
0.000.00%
Last trade - 00:00
- £111.69m
- £107.77m
- £3.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.032 | 0 | 0 | 0 | 3.1 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 1.77 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 11.2 | 2.93 | 5.87 | 6.87 | 10.1 |
Operating Profit | -11.2 | -2.93 | -5.87 | -6.87 | -6.96 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -11.1 | -2.93 | -5.87 | -6.87 | -6.89 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.92 | -2.41 | -4.96 | -5.85 | -6.51 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.92 | -2.41 | -4.96 | -5.85 | -6.51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.92 | -2.41 | -4.96 | -5.85 | -6.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.044 | -0.01 | -0.018 | -0.02 | -0.022 |